Longitudinal study shows moderate exercise improves psoriasis outcomes, highlighting the need for personalized recommendations.
Background Physical activity’s impact on psoriasis treatment outcomes is unclear. This study examines associations between exercise levels and treatment response in psoriasis patients.Methods In a longitudinal study of 1,116 psoriasis patients (2022–2024), physical activity was assessed via MET-min/week and categorized as inactive (<150), low (150–<500), moderate (500–<1000), or high (≥1000). Severity (PASI/BSA) and PASI50 response were evaluated at baseline, week 4, and week 8. Analyses used logistic regression and restricted cubic splines.Results Among participants (74.4% male, mean age 46.1), week 8 PASI50 rates were 61.2% (inactive), 75.1% (low), 69.9% (moderate), and 66.7% (high). Low activity was linked to higher odds of PASI50 (adjusted OR = 1.58; 95% CI: 1.01–2.79) versus inactivity. A J-shaped nonlinear association emerged (p = 0.023): response probability rose rapidly at low exercise levels, peaked at 150–500 MET-min/week, the benefit plateaued or attenuated at higher intensities (≥1000 MET-min/week).Conclusion Moderate physical activity (150–500 MET-min/week) is associated with better psoriasis treatment outcomes, with diminishing benefits at very low or high levels. Findings support personalized, intensity-based exercise recommendations.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: